Cancer Indicators - Orleans County
2007-2009
| Indicator | Data Links | 3 Year Total | County Rate | NYS Rate | Sig.Dif. | NYS Rate exc NYC | Sig.Dif. | County Ranking Group |
|---|---|---|---|---|---|---|---|---|
| All cancers | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 702 | 554.2 | 536.5 | No | 599.7 | Yes | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 702 | 481.0 | 489.6 | No | 520.0 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 248 | 195.8 | 179.9 | No | 204.1 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 248 | 168.5 | 163.0 | No | 173.9 | No | 1st |
| Lip, Oral Cavity, and Pharynx Cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 8 | 6.3* | 11.5 | No | 12.7 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 8 | 4.9* | 10.4 | No | 10.8 | Yes | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 4 | 3.2* | 2.3 | No | 2.4 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 4 | 2.7* | 2.1 | No | 2.0 | No | 4th |
| Colon and rectum cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 67 | 52.9 | 50.4 | No | 53.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 67 | 46.6 | 45.8 | No | 46.2 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 26 | 20.5 | 17.4 | No | 18.5 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 26 | 18.5 | 15.7 | No | 15.7 | No | 4th |
| Lung and bronchus cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 119 | 93.9 | 69.8 | Yes | 83.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 119 | 80.5 | 63.8 | Yes | 72.2 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 78 | 61.6 | 46.9 | Yes | 57.2 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 78 | 53.7 | 42.8 | No | 49.0 | No | 2nd |
| Female breast cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 108 | 170.0 | 147.1 | No | 164.9 | No | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 108 | 140.1 | 126.9 | No | 136.1 | No | 4th |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 20 | 31.5 | 26.7 | No | 28.8 | No | 4th |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 20 | 24.8 | 21.7 | No | 22.2 | No | 4th |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 5 | 7.9* | 8.0 | No | 8.3 | No | 3rd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 5 | 6.9* | 6.8 | No | 6.8 | No | 3rd |
| Cervix uteri cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 2 | 3.1* | 8.9 | No | 7.9 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 2 | 2.9* | 8.3 | No | 7.4 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 1 | 1.6* | 2.7 | No | 2.2 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 1 | 1.1* | 2.3 | No | 1.9 | No | 1st |
| Ovarian cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 17 | 26.8 | 15.2 | No | 16.5 | No | 4th |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 17 | 19.6 | 12.9 | No | 13.4 | No | 4th |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 11.0* | 9.6 | No | 11.0 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 7.8* | 7.8 | No | 8.5 | No | 2nd |
| Prostate cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 90 | 142.5 | 169.1 | No | 186.0 | Yes | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 90 | 131.1 | 166.9 | Yes | 171.2 | Yes | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 11.1* | 18.5 | No | 19.2 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 11.9* | 21.6 | No | 20.8 | No | 1st |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 4 | 6.3* | 6.7 | No | 6.6 | No | 2nd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 4 | 5.6* | 7.2 | No | 6.6 | No | 2nd |
| Melanoma cancer mortality | ||||||||
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 3 | 2.4* | 2.3 | No | 3.1 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 3 | 2.4* | 2.1 | No | 2.7 | No | 2nd |
| Age-adjusted % of women 18 years and older with pap smear in past 3 years (2008-2009) | (Table) (Map) | N/A | 81.5 | 82.7 | No | 82.6 | No | 3nd |
| % of women 40 years and older with mammography screening in past 2 years (2008-2009) | (Table) (Map) | N/A | 78.4 | 79.7 | No | 81.9 | No | 3nd |
N/A: Data not available
*: Fewer than 10 events in the numerator, therefore the rate is unstable
